The benefit of ß-blockers in NYHA-FC I or IV patients has not been established. a Major heart failure trial stopped due to significant survival benefit; Coreg (carvedilol) demonstrates mortality ...
The addition of β-adrenergic ... TX; 1 and the University of Colorado School of Medicine, Denver, CO 2 Survival benefits: angiotensin-converting enzyme inhibitors and β-blockers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback